Invesco Ltd. Adicet Bio, Inc. Transaction History

Invesco Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.76 - $3.45 $3,498 - $6,858	1,988 Added 19.03%	12,434 $29,000
Q4 2023 Feb 12, 2024	BUY	$1.11 - $1.89 $11,595 - $19,742	10,446 New	10,446 $19,000
Q4 2022 Feb 13, 2023	BUY	$7.72 - $21.27 $78,404 - $216,018	10,156 New	10,156 $90,000
Q2 2022 Aug 15, 2022	SELL	$10.26 - $20.81 $1.06 Million - $2.15 Million	-103,423 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $1.19 Million - $2.07 Million	103,423 New	103,423 $2.07 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.